Evidence map›Paper›PMID 34644209›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2022

Targeting

Florian Gueniot, Sebastien Rubin, Pauline Bougaran, Alice Abelanet, Jean Luc Morel, Bruno Bontempi, Carole Proust, Pascale Dufourcq, Thierry Couffinhal, Cecile Duplàa

Open access · greenAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. CRTC1 is a potential target to delay aging-induced cognitive deficit by protecting the integrity of the blood-brain barrier via inhibiting inflammation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Florian GueniotBiology of Cardiovascular Diseases, University of Bordeaux U1034, Bordeaux, France.
Sebastien RubinBiology of Cardiovascular Diseases, University of Bordeaux U1034, Bordeaux, France.
Pauline BougaranBiology of Cardiovascular Diseases, University of Bordeaux U1034, Bordeaux, France.
Alice AbelanetBiology of Cardiovascular Diseases, University of Bordeaux U1034, Bordeaux, France.
Jean Luc MorelUniv. Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France.ORCID 0000-0001-8079-6851
Bruno BontempiUniv. Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France.
Carole ProustBiology of Cardiovascular Diseases, University of Bordeaux U1034, Bordeaux, France.
Pascale DufourcqBiology of Cardiovascular Diseases, University of Bordeaux U1034, Bordeaux, France.
Thierry CouffinhalBiology of Cardiovascular Diseases, University of Bordeaux U1034, Bordeaux, France.
Cecile DuplàaBiology of Cardiovascular Diseases, University of Bordeaux U1034, Bordeaux, France.ORCID 0000-0001-8003-3969
Université de Bordeaux · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood brain barrier (BBB) disruption is a critical component of the pathophysiology of cognitive impairment of vascular etiology (VCI) and associated with Alzheimer's disease (AD). The Wnt pathway plays a crucial role in BBB maintenance, but there is limited data on its role in cognitive pathologies. The E3 ubiquitin ligase PDZRN3 is a regulator of the Wnt pathway. In a murine model of VCI, overexpressing

Indexed as

Alzheimer DiseaseBlood-Brain BarrierUbiquitin-Protein LigasesAnimalsBiological TransportCapillary PermeabilityEndothelial CellsHomeostasisMicePDZRN3 protein, mouseUbiquitin-Protein Ligasesblood brain barrierendothelial tight junctionVascular cognitive impairmentvascular permeabilityWnt pathway

Identifiers

PMID34644209
PMCPMC9051145
OpenAlexW3207572466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.